Document is current
Any future updates will be listed below
-
Authors
Ohlrogge, Amelie H. https://orcid.org/0000-0002-3969-624X
Camen, Stephan
Nagel, Lina
Brederecke, Jan
Jensen, Märit
Stenmans, Ewgenia
Engler, Daniel
Schulte, Christian
Albrecht, Jan
Csengeri, Dora
Kirchhof, Paulus
Cheng, Bastian
Petersen, Marvin
Mayer, Carola
Börschel, Christin S.
Wenzel, Jan-Per
Blankenberg, Stefan
Kühn, Simone
Thomalla, Götz
Schnabel, Renate B.
-
Funding
Funding for this research was provided by:
Deutsche Stiftung für Herzforschung ((F/29/19))
H2020 European Research Council (648131)
H2020 European Research Council (847770)
Deutsches Zentrum für Herz-Kreislaufforschung (81Z1710103)
Deutsches Zentrum für Herz-Kreislaufforschung (81Z0710114)
Bundesministerium für Bildung und Forschung (01ZX1408A)
ERACoSysMed3 (031L0239)
Deutsche Herzstiftung (Wolfgang Seefried project funding)
Deutsche Herzstiftung (Wolfgang Seefried project funding)
Universitätsklinikum Hamburg-Eppendorf (UKE)
- License Information
-
More Information
Article History
Received: 26 January 2024
Accepted: 18 November 2024
First Online: 27 November 2024
Declarations
:
: JPW received funding of the German Foundation of Heart Research (F/29/19) and travel grants from Boston Scientific, both unrelated to the current project. DC received the Wolfgang Seefried Project funding of the German Heart foundation e.V. RBS has received funding from the European Research Council (ERC) under the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 648131, from the European Union’s Horizon 2020 research and innovation programme under the grant agreement No 847770 (AFFECT-EU) and German Center for Cardiovascular Research (DZHK e.V.) (81Z1710103 and 81Z0710114); German Ministry of Research and Education (BMBF 01ZX1408A) and ERACoSysMed3 (031L0239). Wolfgang Seefried project funding German Heart Foundation. RBS has received lecture fees and advisory board fees from BMS/Pfizer outside this work.
